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The TL (thymus leukemia) antigens are demonstrable only on thymocytes 
and leukemia cells (1, 2). Therefore to preclude the production of TL antibody, 
when immunizing mice against some other antigen, we have sometimes elected 
to immunize with spleen and lymph node cells, omitting thymocytes. Contrary 
to expectation, this does not necessarily prevent the formation of TL antibody, 
and so we were obliged to test which of the two following explanations might 
account for this paradox: 
(a)  TL antigen is present on cells  outside the  thymus  (although such cells 
have never been demonstrated), and it is these that induce production of TL 
antibody on inoculation into TL- recipients. 
(b) TL antigen is not present on cells outside the thymus, but precursor cells 
(which are known to be present in spleen and bone marrow and to repopulate 
the  thymus of lethally irradiated mice with TL  + cells [3]) become TL  + after 
inoculation, under the influence of the recipient's thymus, and then induce the 
formation of TL antibody. 
The first experiment is summarized in Table I: Mice of the congenic A/TL- 
strain (4)  were thymectomized between 4 and  6 wk of age, while  others  were 
subjected to the same operation without removal of the thymus (sham thymec- 
tomy). Approximately 1 wk later, mice of both groups received a subcutaneous 
inoculation of 2-3  X  107 washed cells  (thymus, spleen,  lymph node,  or bone 
marrow) from A  strain  (TL  +)  donors.  Starting  2 wk later,  the immunization 
was repeated intraperitoneally five times at weekly intervals. 10 days after the 
last immunization the serum of each mouse was titrated against A strain thymo- 
cytes for the presence of TL antibody. 
Among the sham-thymectomized mice, TL antibody was made by 8/8 mice 
immunized with spleen cells, 2/5  mice immunized with lymph node cells,  and 
3/5 mice immunized with bone marrow cells.  Of the thymectomized mice, 5/5 
immunized with thymocytes produced TL antibody,  but  only  1/18  mice  ira- 
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munized  with  spleen  cells,  lymph  node  cells,  or  bone marrow  cells  [this  one 
exception  being  a  thymectomized mouse  immunized  with  spleen  cells,  which 
gave the minimum titer tested for (1: 10)]. 
This result clearly favored the second explanation given above, namely that 
TL antibody production is caused by maturation  of TL- precursor cells in the 
inoculum into TL  + thymocytes, under the influence of the recipient's thymus, 
the  exceptional  mouse  being  either  inadequately  thvmectomized  or  having 
aberrant  thymic tissue  (5). 
TABLE I 
TL Antibody Production by Thymectomlzed and Sham-ThymeclonKzed A/TL- Mice Imrmmized 
ze,#h A Strain Cells 
Immunized with  Cytoto×ic titer* of serum vs. A strain  Treatment of recipient  A strain cells from  thymocytes (anti-TL) (reciprocal) 
Thymectomy  Thymus  640, 640, 320, 320, 320 
Spleen  I0,  <10:~, <10,  <10,  <10,  <10, 
<10,  <10 
<10, <10,  <10, <10 <10 
<10, <10, <10, <10, <10 
Lymph nodes 
Bone marrow 
Sham thymectomy  Spleen 
Lymph nodes 
Bone marrow 
320, 160, 160, 80, 80, 80, 40, 40 
80, 40, <10, <I0, <10 
80, 40, 40, < 10, < 10 
Interpretation: Intact  mice can  make  TL antibody  when  immunized  with  cells from 
hemopoietic organs other than thymus, but thymeetomized mice cannot. 
* For each mouse individually  (end point  50c7~ cells lysed).  Specificity control:  all sera 
were negative (< 109~ cells lysed) against syngeneic (A/TL-) thymocytes. 
< 10: serum negative (< 10% cells lysed) at lowest dilution tested  (1:10). 
The second experiment  was designed  to test  the possibility that  the failure 
of thymectomized mice to produce TL antibody when immunized with hemo- 
poietic cells other than thymocytes might be due to immunosuppression caused 
by  thymectomy  (even  though  thymectomy had  been  carried  out  long  after 
birth) ; otherwise it might be argued that a thymectomized mouse is capable of 
responding  only  to  cells  containing  a  large  amount  of  TL  antigen,  i.e.,  to 
thymocytes.  For  the  second  experiment,  thymectomized  and  sham-thymec- 
tomized A/TL-  congenic mice were used  as before,  but  the immunizing  cells 
were  taken  from  another  A  strain  congenic  stock,  A/Thy-l.1  (6)  formerly 
called A/0-AKR (see reference 7). In this instance the recipient has the oppor- 
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(formerly 0-AKR)  (Table II). The immunizing schedule was as before, but the 
sera were tested  against AKR thymocytes for anti-Thy-l.1  as well  as against 
strain A thymocytes for anti-TL. 
The result (summarized in Table III) was decisive. Immunization with either 
thymocytes or spleen  cells  produced roughly equivalent titers  of anti-Thy-l.1 
TABLE II 
Phenotypes of the Four Mouse Strains  Used 
Strain  Thy-I  TL 
A  2  + 
A/TL-  2  -- 
A/Thy-l.1  1  + 
AKR  1  -- 
TABLE III 
Production of TL and  Thy-l.1  Antibody by Thymectomized and Sham-Thymectomized A/TL- 
Mice Immunized  with A/Thy-l.1 Cells 
Treatment of recipient 
Immunized with  Cytotoxic  titer* (reciprocal) vs. thymocytes  from 
A/Thy-l.1 
cells from  Strain A (anfi-TL)  Strain AKR (anti-Thy-l.1) 
Thvmectomv  Thymus  1280,  640, 640, 640, 640  1280, 1280, 1280, 640, 
640 
Sham thymectomy 
Spleen  < 10,  < 10,  < 10,  < 10,  320,  320, 320, 100, 100, 80 
<10, <10 
Thymus  1280,  1280, 320  1280, 1280, 640 
Spleen  320, 320, 160, 160  640, 640, 320, 320 
Interpretation: Absence of thymus in the recipient makes no difference to its capacity to 
make Thy-1 antibody,  but precludes the formation of TL antibody except where the inocu- 
lum is TL  +, i.e., contains mature thymocytes. 
* For each mouse individually. Specificity control: all sera were negative against syngeneic 
(A/TL-) thymocytes. 
in both thymectomized and sham-thymectomized groups. Immunization with 
thymocytes also produced  roughly equivalent  titers  of TL  antibody  in  both 
thymectomized  and  sham-thymectomized  groups.  But  immunization  with 
spleen, while producing TL titers of 160-320 in sham-thymectomized recipients, 
failed to produced any anti-TL response in thymectomized recipients. Immuno- 
suppression is thus effectively ruled out as a cause for the disparate TL titers of 
thymectomized vs. sham-thymectomized mice immunized with spleen  cells. 
COMMENT 
These findings show that the production of TL antibody by mice immunized 
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presence of a  thymus in the recipient,  and this implies that production of TL 
antibody by such mice requires first the maturation of TL- precursors into TL  + 
thymocytes. Whether the  cells must go to the  thymus for this to happen,  or 
whether  it  can happen  at  the  site  of inoculation  (subcutaneous or intraperi- 
toneal) under the influence of a thymic hormone, is not decided by the present 
experiments. Possibly the capacity of the thymectomized TL- mouse to make 
TL antibody when immunized with spleen cells could form the basis of an assay 
for thymic hormone. 
As 2/5  sham-thymectomized mice produced TL antibody when immunized 
with lymph node cells (Table I), it appears that lymph nodes, as well as spleen 
and bone marrow, contain some thymocyte precursors; but the point needs more 
thorough investigation. 
SUMMARY 
TL- mice make TL antibody when immunized with spleen or bone marrow 
cells  from TL  +  donors,  despite  the  fact  that  these  cells  do  not  express  TL 
antigen.  This  has  been  shown  to  depend  on  maturation  of TL- precursors, 
contained in  the  inoculum,  into TL  +  cells  under  influence  of  the  recipient's 
thymus; the differentiated TL  + cells then evoke production of TL antibody. 
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